Seres Therapeutics: 3Q Earnings Snapshot

November 5, 2019 GMT

CAMBRIDGE, Mass. (AP) _ Seres Therapeutics Inc. (MCRB) on Tuesday reported a loss of $16.4 million in its third quarter.

The Cambridge, Massachusetts-based company said it had a loss of 23 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share.

The drug developer posted revenue of $7 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $6.7 million.

The company’s shares closed at $3.80. A year ago, they were trading at $7.28.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB